The Charcot foot

Medical Clinics of North America

Volumn 97, Issue 5, 2013, Pages 847-856

  Rogers, Lee C ^a,b   Frykberg, Robert G ^c  

^a Valley Presbyterian Hospital   (United States)

^b WESTERN UNIVERSITY OF HEALTH SCIENCES   (United States)

^c CARL T HAYDEN VA MEDICAL CENTER   (United States)

Author keywords

Charcot foot; Joints; Neuroarthropathy; Soft tissues

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN;

ANKLE FOOT ORTHOSIS; ARTHRODESIS; BONE BIOPSY; BONE SCINTISCANNING; CAST APPLICATION; CHARCOT FOOT; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; DISEASE CLASSIFICATION; ELECTROMAGNETIC BONE STIMULATOR; FOOT RADIOGRAPHY; FOOT SURGERY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HUMAN; LIFESTYLE MODIFICATION; NEUROPATHIC JOINT DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC CAST; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TEMPERATURE MEASUREMENT;

CHARCOT FOOT; JOINTS; NEUROARTHROPATHY; SOFT TISSUES;

ANTI-BACTERIAL AGENTS; ARTHROPATHY, NEUROGENIC; DEBRIDEMENT; DIABETIC FOOT; HEALTH BEHAVIOR; HUMANS; LIFE STYLE; PROGNOSIS; RARE DISEASES;

EID: 84883236113     PISSN: 00257125     EISSN: 15579859     Source Type: Journal    
DOI: 10.1016/j.mcna.2013.04.003     Document Type: Review

References (44)

1. Frykberg R.G. Charcot arthropathy: pathogenesis and management. Wounds 2000, 12(6 Suppl B):35B-42B.
2. Frykberg R.G., Mendeszoon E. Management of the diabetic Charcot foot. Diabetes Metab Res Rev 2000, 16(Suppl 1):S59-S65.
3. Foltz K.D., Fallat L.M., Schwartz S. Usefulness of a brief assessment battery for early detection of Charcot foot deformity in patients with diabetes. JFoot Ankle Surg 2004, 43(2):87-92.
4. Valabhji J. Foot problems in patients with diabetes and chronic kidney disease. JRen Care 2012, 38(Suppl 1):99-108.
5. Armstrong D.G., Todd W.F., Lavery L.A., et al. The natural history of acute Charcot's arthropathy in a diabetic foot specialty clinic. Diabet Med 1997, 14:357-363.
6. Jeffcoate W.J. Theories concerning the pathogenesis of the acute Charcot foot suggest future therapy. Curr Diab Rep 2005, 5(6):430-435.
7. Boyce B.F., Xing L. Functions of RANKL/RANK/OPG in bone modeling and remodeling. Arch Biochem Biophys 2008, 473(2):139-146.
8. Korzon-Burakowska A., Jakobkiewicz-Banecka J., Fiedosiuk A., et al. Osteoprotegerin gene polymorphism in diabetic Charcot neuroarthropathy. Diabet Med 2012, 29(6):771-775.
9. Chantelau E. The perils of procrastination: effects of early vs. delayed detection and treatment of incipient Charcot fracture. Diabet Med 2005, 22(12):1707-1712.
10. Armstrong D.G., Peters E.J. Charcot's arthropathy of the foot. JAm Podiatr Med Assoc 2002, 92(7):390-394.
11. Armstrong D.G., Lavery L.A. Monitoring healing of acute Charcot's arthropathy with infrared dermal thermometry. JRehabil Res Dev 1997, 34:317-321.
12. Frykberg R.G. Osteoarthropathy. Clin Podiatr Med Surg 1987, 4:351-356.
13. Rogers L.C., Bevilacqua N.J. Imaging of the Charcot foot. Clin Podiatr Med Surg 2008, 25(2):263-274. vii.
14. Ledermann H.P., Morrison W.B. Differential diagnosis of pedal osteomyelitis and diabetic neuroarthropathy: MR Imaging. Semin Musculoskelet Radiol 2005, 9(3):272-283.
15. Sella E.J., Grosser D.M. Imaging modalities of the diabetic foot. Clin Podiatr Med Surg 2003, 20(4):729-740.
16. Hopfner S., Krolak C., Kessler S., et al. Preoperative imaging of Charcot neuroarthropathy in diabetic patients: comparison of ring PET, hybrid PET, and magnetic resonance imaging. Foot Ankle Int 2004, 25(12):890-895.
17. Pickwell K.M., van Kroonenburgh M.J., Weijers R.E., et al. F-18 FDG PET/CT scanning in Charcot disease: a brief report. Clin Nucl Med 2011, 36(1):8-10.
18. Frykberg R.G., Rogers L.C. Classification of the Charcot foot. The diabetic Charcot foot: principles and management 2010, 55-64. Data Trace Publishing Company, Brooklandville (MD). R.G. Frykberg (Ed.).
19. Rogers L.C., Frykberg R.G., Armstrong D.G., et al. The Charcot foot in diabetes. JAm Podiatr Med Assoc 2011, 101(5):437-446.
20. Sanders L.J., Mrdjencovich D. Anatomical patterns of bone and joint destruction in neuropathic diabetics. Diabetes 1991, 40(Suppl 1):529A.
21. Larsen K., Fabrin J., Holstein P.E. Incidence and management of ulcers in diabetic Charcot feet. JWound Care 2001, 10(8):323-328.
22. Eichenholtz S.N. Charcot Joints 1966, Charles C. Thomas, Springfield (IL).
23. Shibata T., Tada K., Hashizume C. The results of arthrodesis of the ankle for leprotic neuroarthropathy. JBone Joint Surg Am 1990, 72:749-756.
24. Rogers L.C., Bevilacqua N.J. The diagnosis of Charcot foot. Clin Podiatr Med Surg 2008, 25(1):43-51. vi.
25. Viswanathan V., Kesavan R., Kavitha K.V., et al. Evaluation of Rogers Charcot foot classification system in South Indian diabetic subjects with Charcot foot. JDiabetic Foot Complications 2012, 4:67-70.
26. Rogers L.C., Frykberg R.G., Armstrong D.G., et al. The Charcot foot in diabetes. DiabetesCare 2011, 34:2123-2129.
27. Sanders L., Frykberg R.G. The Charcot foot (pied de Charcot). Levin and O'Neal's the diabetic foot 2007, 257-283. Mosby Elsevier, Philadelphia. J.H. Bowker, M. Pfeiffer (Eds.).
28. Hartsell H.D., Brand R.A., Saltzman C.L. Total contact casting: its effect on contralateral plantar foot pressure. Foot Ankle Int 2002, 23(4):330-334.
29. Lavery L.A., Higgins K.R., Lanctot D.R., et al. Home monitoring of foot skin temperatures to prevent ulceration. Diabetes Care 2004, 27(11):2642-2647.
30. Hartsell H.D., Fellner C., Saltzman C.L. Pneumatic bracing and total contact casting have equivocal effects on plantar pressure relief. Foot Ankle Int 2001, 22(6):502-506.
31. Jude E.B., Selby P.L., Burgess J., et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: A double-blind randomised controlled trial. Diabetologia 2001, 44:2032-2037.
32. Jude E.B., Selby P.L., Burgess J., et al. Bisphosphonates in the treatment of Charcot neuroarthropathy: a double-blind randomised controlled trial. Diabetologia 2001, 44(11):2032-2037.
33. Selby P.L., Young M.J., Boulton A.J. Bisphosphonates: a new treatment for diabetic Charcot neuroarthropathy?. Diabet Med 1994, 11(1):28-31.
34. Bem R., Jirkovska A., Fejfarova V., et al. Intranasal calcitonin in the treatment of acute Charcot neuroosteoarthropathy: a randomized controlled trial. Diabetes Care 2006, 29(6):1392-1394.
35. Pitocco D., Ruotolo V., Caputo S., et al. Six-Month Treatment With Alendronate in Acute Charcot Neuroarthropathy: a randomized controlled trial. Diabetes Care 2005, 28(5):1214-1215.
36. Game F.L., Catlow R., Jones G.R., et al. Audit of acute Charcot's disease in the UK: the CDUK study. Diabetologia 2012, 55:32-35.
37. Petrisor B., Lau J.T. Electrical bone stimulation: an overview and its use in high risk and Charcot foot and ankle reconstructions. Foot Ankle Clin 2005, 10(4):609-620. vii-viii.
38. Wang J.C., Le A.W., Tsukuda R.K. Anew technique for Charcot's foot reconstruction. JAm Podiatr Med Assoc 2002, 92(8):429-436.
39. Baravarian B., Van Gils C.C. Arthrodesis of the Charcot foot and ankle. Clin Podiatr Med Surg 2004, 21(2):271-289.
40. Bevilacqua N.J., Rogers L.C. Surgical management of Charcot midfoot deformities. Clin Podiatr Med Surg 2008, 25(1):81-94. vii.
41. Pinzur M.S., Sage R., Stuck R., et al. Atreatment algorithm for neuropathic (Charcot) midfoot deformity. Foot Ankle 1993, 14(4):189-197.
42. Pinzur M.S., Sostak J. Surgical stabilization of nonplantigrade Charcot arthropathy of the midfoot. Am J Orthop 2007, 36(7):361-365.
43. Saltzman C.L., Johnson K.A., Goldstein R.H., et al. The patellar tendon-bearing brace as treatment for neurotrophic arthropathy: a dynamic force monitoring study. Foot Ankle 1992, 13:14-21.
44. Saltzman C.L., Hagy M.L., Zimmerman B., et al. How effective is intensive nonoperative initial treatment of patients with diabetes and Charcot arthropathy of the feet?. Clin Orthop Relat Res 2005, (435):185-190.